What is CAR T Cell Therapy?

IMF Chief Medical Officer Joseph Mikhael, MD, discusses CAR T-cell therapy (chimeric antigen receptor), an approach for targeting BCMA as part of multiple myeloma treatment. Please subscribe to our channel! Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE Visit our website at: https://www.myeloma.org Find us online: Facebook:   / myeloma   Twitter: @IMFMyeloma (  / imfmyeloma  ) Instagram: @imfmyeloma (  / imfmyeloma  ) LinkedIn:   / international-myeloma-foundation  ) Support the IMF! http://bit.ly/WskQHC Category Nonprofits & Activism License Standard YouTube License